Viewing Study NCT06984094


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-04-07 @ 4:15 PM
Study NCT ID: NCT06984094
Status: RECRUITING
Last Update Posted: 2025-08-08
First Post: 2025-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
Sponsor: Clover Biopharmaceuticals AUS Pty
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module